What is the recommended management of immune reconstitution inflammatory syndrome (IRIS) in patients receiving antiretroviral therapy?

Management of Immune Reconstitution Inflammatory Syndrome (IRIS)

Continue antiretroviral therapy (ART) in most cases of IRIS while optimizing pathogen-specific treatment, and reserve corticosteroids for severe cases, particularly tuberculosis-IRIS and CNS involvement. 1

General Management Principles

The cornerstone of IRIS management involves maintaining ART while addressing the underlying opportunistic infection. 2, 3

• Do not routinely interrupt ART – Continue antiretroviral therapy in the vast majority of IRIS cases, as the benefits of immune reconstitution outweigh the inflammatory complications. 3, 4
• Optimize antimicrobial therapy – Ensure the underlying opportunistic infection is being treated with appropriate pathogen-specific therapy at optimal doses. 3, 4
• Exclude alternative diagnoses – Rule out antimicrobial drug resistance, new infections, drug toxicity, or malignancy before confirming IRIS diagnosis. 3, 5

Severity-Based Treatment Algorithm

Mild IRIS

• Symptomatic management alone may suffice for mild cases with minimal functional impairment. 3
• NSAIDs can be used for symptomatic relief of inflammatory symptoms. 3, 4

Moderate to Severe IRIS

• Corticosteroids are the primary anti-inflammatory treatment for severe IRIS, with the strongest evidence supporting their use in paradoxical tuberculosis-IRIS. 3, 4
• Prednisone has been shown in randomized controlled trials to reduce morbidity and improve symptoms in paradoxical TB-IRIS. 3
• Use corticosteroids only when the diagnosis of IRIS is certain, given their significant side effects including increased infection risk. 3

Pathogen-Specific Management

Tuberculosis-IRIS

• Continue ART and tuberculosis treatment in most cases. 1
• Prednisone is indicated for moderate to severe paradoxical TB-IRIS based on randomized trial evidence. 3
• For tuberculous meningitis with IRIS: This represents a life-threatening scenario requiring aggressive intervention. 1, 3
  • Administer high-dose corticosteroids immediately. 1
  • Consider ART interruption if level of consciousness is depressed or there is severe neurological deterioration. 3, 4
  • This is one of the few scenarios where temporary ART discontinuation may be warranted. 3

Cryptococcal Meningitis-IRIS

• Close monitoring for increased intracranial pressure is essential, as this is a major cause of morbidity and mortality. 1
• Aggressive management of elevated intracranial pressure through serial lumbar punctures or CSF drainage is critical. 1
• Corticosteroids may be considered for severe cases, though evidence is less robust than for TB-IRIS. 3
• Ensure negative CSF cultures before considering earlier ART initiation (at 2 weeks vs 4 weeks after antifungal therapy). 1

Mycobacterial IRIS (including MAC)

• Corticosteroids have been used for severe cases of disseminated Mycobacterium avium complex IRIS. 3
• Continue both ART and antimycobacterial therapy. 2

Viral IRIS (CMV, HSV, VZV)

• Avoid corticosteroids in viral forms of IRIS due to concerns about worsening viral replication. 3
• Focus on optimizing antiviral therapy. 3

Additional Therapeutic Considerations

Procedural Interventions

• Drainage procedures play an important role for patients with abscess formation or fluid collections (e.g., pleural effusions, lymph node suppuration). 4
• Serial lumbar punctures are critical for managing elevated intracranial pressure in cryptococcal or TB meningitis-IRIS. 1

Alternative Anti-inflammatory Agents

Limited anecdotal evidence exists for other agents when corticosteroids are contraindicated or ineffective: 4

• Pentoxifylline
• Montelukast
• Thalidomide
• Hydroxychloroquine

These should be considered experimental and used only in consultation with specialists. 4

When to Consider ART Interruption

ART interruption should be reserved for life-threatening IRIS only, particularly: 3, 4

• CNS involvement with depressed consciousness (especially TB meningitis-IRIS)
• Severe respiratory compromise
• Hemodynamic instability unresponsive to other interventions

This is a last-resort measure, as interrupting ART carries risks of HIV disease progression. 4, 5

Prevention Strategies

While not strictly management, understanding prevention informs clinical decision-making: 6, 5

• Initiating ART at CD4 counts >350 cells/μL prevents most IRIS cases. 6
• Screening and treating opportunistic infections before ART initiation reduces IRIS risk. 5
• However, current guidelines prioritize early ART initiation (within 2 weeks for most OIs) despite IRIS risk, as delaying ART increases mortality. 1

Critical Pitfalls to Avoid

• Do not assume all clinical deterioration after ART initiation is IRIS – Always exclude drug resistance, new infections, drug toxicity, and non-infectious complications. 3, 5
• Do not use corticosteroids indiscriminately – Confirm IRIS diagnosis first, as corticosteroids can worsen uncontrolled infections. 3
• Do not routinely stop ART – This should only occur in life-threatening situations, primarily severe CNS IRIS. 3, 4
• Do not delay management of elevated intracranial pressure in cryptococcal or TB meningitis – This is a medical emergency requiring immediate intervention. 1